The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
The Origin of Ovarian Cancer Species and Precancerous Landscape
Open accessAbstract
Unlike other human cancers, in which all primary tumors arise de novo, ovarian epithelial cancers are primarily imported from either endometrial or fallopian tube epithelium. The prevailing paradigm in the genesis of high-grade serous carcinoma (HGSC), the most common ovarian cancer, posits development in fallopian tubes through stepwise tumor progression. In recent years, progress has been made not only in gathering terabytes of omics data but also in detailing the histologic-molecular correlations required to look into and make sense of the tissue origin of HGSC. This emerging paradigm is changing many facets of ovarian cancer research and routine gynecology practice. The precancerous landscape in fallopian tubes contains multiple concurrent precursor lesions including serous tubal intraepithelial carcinoma (STIC), with genetic heterogeneity providing a platform for HGSC evolution. Mathematical models imply that a prolonged time (decades) elapses from appearance of a TP53 mutation, the earliest known molecular alteration, to appearance of a STIC, followed by a shorter span (6 years) for progression to a HGSC. Genetic predisposition accelerates the trajectory, but this time line may allow for early diagnosis of HGSC and STIC, reasonably followed by an intention-to-cure surgery. In this review, we discuss the recent advances of this tubal paradigm and its biological and clinical implications alongside the promise and challenge of studying precancerous lesions of HGSC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Fallopian tube secretory cell expansion: a sensitive biomarker for ovarian serous carcinogenesis.
Wang, Y., Li, L., Wang, Y., Tang, S. N., & Zheng, W. (2015) · Europe PMC (PubMed Central) · Cited by 18
Self-citationRetractedThe Structure of Scientific Revolutions
Kuhn, T. S., & Schlegel, R. (1963) · Physics Today · doi:10.1063/1.3050879 · Cited by 35,538
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
The Structure of Scientific Revolutions: 50th Anniversary Edition
Kuhn, T. S., & Hacking, I. (2012) · doi:10.7208/chicago/9780226458144.001.0001 · Cited by 21,170
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Variation in cancer risk among tissues can be explained by the number of stem cell divisions
Tomasetti, C., & Vogelstein, B. (2015) · Science · doi:10.1126/science.1260825 · Cited by 1,927
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Kurman, R. J., & Shih, I.-M. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf3d79 · Cited by 1,846
Self-citationDomchek, S. M. (2010) · JAMA · doi:10.1001/jama.2010.1237 · Cited by 1,494
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
Costello, J. F., Frühwald, M. C., Smiraglia, D. J., Rush, L. J., Robertson, G. P., Gao, X., Wright, F. A., Feramisco, J. D., Peltomäki, P., Lang, J. C., et al. (2000) · Nature Genetics · doi:10.1038/72785 · Cited by 1,357
Buys, S. S. (2011) · JAMA · doi:10.1001/jama.2011.766 · Cited by 1,323
Kindelberger, D. W., Lee, Y., Miron, A., Hirsch, M. S., Feltmate, C., Medeiros, F., Callahan, M. J., Garner, E. O., Gordon, R. W., Birch, C., et al. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213335.40358.47 · Cited by 1,113
The Dualistic Model of Ovarian Carcinogenesis
Kurman, R. J., & Shih, I.-M. (2016) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.11.011 · Cited by 923
Self-citationA candidate precursor to serous carcinoma that originates in the distal fallopian tube
Lee, Y., Miron, A., Drapkin, R., Nucci, M., Medeiros, F., Saleemuddin, A., Garber, J., Birch, C., Mou, H., Gordon, R., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2091 · Cited by 898
Menon, U., Gentry-Maharaj, A., Hallett, R., Ryan, A., Burnell, M., Sharma, A., Lewis, S., Davies, S., Philpott, S., Lopes, A., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70026-9 · Cited by 829
Collaborative Group on Epidemiological Studies of Ovarian Cancer (2008) · The Lancet · doi:10.1016/s0140-6736(08)60167-1 · Cited by 822
Piek, J. M. J., van Diest, P. J., Zweemer, R. P., Jansen, J. W., Poort‐Keesom, R. J. J., Menko, F. H., Gille, J. J. P., Jongsma, A. P. M., Pals, G., Kenemans, P., et al. (2001) · The Journal of Pathology · doi:10.1002/path.1000 · Cited by 787
High grade serous ovarian carcinomas originate in the fallopian tube
Labidi-Galy, S. I., Papp, E., Hallberg, D., Niknafs, N., Adleff, V., Noe, M., Bhattacharya, R., Novak, M., Jones, S., Phallen, J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00962-1 · Cited by 759
Self-citationPerets, R., Wyant, G. A., Muto, K. W., Bijron, J. G., Poole, B. B., Chin, K. T., Chen, J. Y. H., Ohman, A. W., Stepule, C. D., Kwak, S., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.10.013 · Cited by 596
The distal fallopian tube: a new model for pelvic serous carcinogenesis
Crum, C. P., Drapkin, R., Miron, A., Ince, T. A., Muto, M., Kindelberger, D. W., & Lee, Y. (2007) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e328011a21f · Cited by 512
The mutational landscape of normal human endometrial epithelium
Moore, L., Leongamornlert, D., Coorens, T. H. H., Sanders, M. A., Ellis, P., Dentro, S. C., Dawson, K. J., Butler, T., Rahbari, R., Mitchell, T. J., et al. (2020) · Nature · doi:10.1038/s41586-020-2214-z · Cited by 499
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis
Moran, S., Martínez-Cardús, A., Sayols, S., Musulén, E., Balañá, C., Estival-Gonzalez, A., Moutinho, C., Heyn, H., Diaz-Lagares, A., de Moura, M. C., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30297-2 · Cited by 484
Parker, W. H., Feskanich, D., Broder, M. S., Chang, E., Shoupe, D., Farquhar, C. M., Berek, J. S., & Manson, J. E. (2013) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3182864350 · Cited by 454
Bashashati, A., Ha, G., Tone, A., Ding, J., Prentice, L. M., Roth, A., Rosner, J., Shumansky, K., Kalloger, S., Senz, J., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4230 · Cited by 421
Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin?
Przybycin, C. G., Kurman, R. J., Ronnett, B. M., Shih, I.-M., & Vang, R. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181ef7b16 · Cited by 410
Self-citationKuhn, E., Kurman, R. J., Vang, R., Sehdev, A. S., Han, G., Soslow, R., Wang, T., & Shih, I. (2012) · The Journal of Pathology · doi:10.1002/path.3023 · Cited by 387
Self-citationEvaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers.
Kinde, I., Bettegowda, C., Wang, Y., Wu, J., Agrawal, N., Shih, I.-M., Kurman, R., Dao, F., Levine, D. A., Giuntoli, R., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004952 · Cited by 327
Self-citationTelomere Length Abnormalities Occur Early in the Initiation of Epithelial Carcinogenesis
Meeker, A. K., Hicks, J. L., Iacobuzio-Donahue, C. A., Montgomery, E. A., Westra, W. H., Chan, T. Y., Ronnett, B. M., & De Marzo, A. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0984-03 · Cited by 306
Folkins, A. K., Jarboe, E. A., Saleemuddin, A., Lee, Y., Callahan, M. J., Drapkin, R., Garber, J. E., Muto, M. G., Tworoger, S., & Crum, C. P. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.01.012 · Cited by 293
McAlpine, J. N., Hanley, G. E., Woo, M. M. M., Tone, A. A., Rozenberg, N., Swenerton, K. D., Gilks, C. B., Finlayson, S. J., Huntsman, D. G., & Miller, D. M. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.01.003 · Cited by 286
Fallopian tube precursors of ovarian low‐ and high‐grade serous neoplasms
Vang, R., Shih, I., & Kurman, R. J. (2013) · Histopathology · doi:10.1111/his.12046 · Cited by 281
Self-citationEarly Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum
Hulbert, A., Jusue-Torres, I., Stark, A., Chen, C., Rodgers, K., Lee, B., Griffin, C., Yang, A., Huang, P., Wrangle, J., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1371 · Cited by 275
Self-citationCell Origins of High-Grade Serous Ovarian Cancer
Kim, J., Park, E., Kim, O., Schilder, J., Coffey, D., Cho, C.-H., & Bast, R. (2018) · Cancers · doi:10.3390/cancers10110433 · Cited by 264
Wang, Y., Li, L., Douville, C., Cohen, J. D., Yen, T.-T., Kinde, I., Sundfelt, K., Kjær, S. K., Hruban, R. H., Shih, I.-M., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aap8793 · Cited by 243
Self-citationDucie, J., Dao, F., Considine, M., Olvera, N., Shaw, P. A., Kurman, R. J., Shih, I.-M., Soslow, R. A., Cope, L., & Levine, D. A. (2017) · Nature Communications · doi:10.1038/s41467-017-01217-9 · Cited by 224
Self-citationEckert, M. A., Pan, S., Hernandez, K. M., Loth, R. M., Andrade, J., Volchenboum, S. L., Faber, P., Montag, A., Lastra, R., Peter, M. E., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0607 · Cited by 216
Hu, Z., Artibani, M., Alsaadi, A., Wietek, N., Morotti, M., Shi, T., Zhong, Z., Santana Gonzalez, L., El-Sahhar, S., Carrami, E. M., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.01.003 · Cited by 200
Visvanathan, K., Vang, R., Shaw, P., Gross, A., Soslow, R., Parkash, V., Shih, I.-M., & Kurman, R. J. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31822f58bc · Cited by 177
Self-citationSecretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube
Chen, E. Y., Mehra, K., Mehrad, M., Ning, G., Miron, A., Mutter, G. L., Monte, N., Quade, B. J., McKeon, F. D., Yassin, Y., et al. (2010) · The Journal of Pathology · doi:10.1002/path.2739 · Cited by 161
Validation of an Algorithm for the Diagnosis of Serous Tubal Intraepithelial Carcinoma
Vang, R., Visvanathan, K., Gross, A., Maambo, E., Gupta, M., Kuhn, E., Li, R. F., Ronnett, B. M., Seidman, J. D., Yemelyanova, A., et al. (2012) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31823b8831 · Cited by 159
Self-citationDehari, R., Kurman, R. J., Logani, S., & Shih, I. (2007) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31802cbbe9 · Cited by 150
Self-citationKuhn, E., Meeker, A. K., Wang, T., Sehdev, A. E. S., Kurman, R. J., & Shih, I. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181dcede7 · Cited by 148
Self-citationBRCA1/2-related ovarian cancers are of tubal origin: a hypothesis
Piek, J. M. J., Verheijen, R. H. M., Kenemans, P., Massuger, L. F. A. G., Bulten, H., & van Diest, P. J. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00365-2 · Cited by 147
Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions
Wu, R., Wang, P., Lin, S., Zhang, M., Song, Q., Chu, T., Wang, B. G., Kurman, R. J., VANG, R. S., Kinzler, K. W., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5219 · Cited by 141
Self-citationSherman‐Baust, C. A., Kuhn, E., Valle, B. L., Shih, I., Kurman, R. J., Wang, T., Amano, T., Ko, M. S. H., Miyoshi, I., Araki, Y., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4353 · Cited by 134
Self-citationHigh-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression
Roh, M. H., Yassin, Y., Miron, A., Mehra, K. K., Mehrad, M., Monte, N. M., Mutter, G. L., Nucci, M. R., Ning, G., McKeon, F., et al. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.119 · Cited by 123
Incidental Nonuterine High-grade Serous Carcinomas Arise in the Fallopian Tube in Most Cases
Gilks, C. B., Irving, J., Köbel, M., Lee, C., Singh, N., Wilkinson, N. S., & McCluggage, W. G. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000353 · Cited by 123
Pathogenesis and the Role of ARID1A Mutation in Endometriosis-related Ovarian Neoplasms
Maeda, D., & Shih, I. (2012) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e31827bc24d · Cited by 122
Self-citationNext-Generation Sequencing of Tubal Intraepithelial Carcinomas
McDaniel, A. S., Stall, J. N., Hovelson, D. H., Cani, A. K., Liu, C., Tomlins, S. A., & Cho, K. R. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1618 · Cited by 118
Meeker, A. K., & Argani, P. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000048775.04140.92 · Cited by 102
Somatic Mutations of PPP2R1A in Ovarian and Uterine Carcinomas
Shih, I., Panuganti, P. K., Kuo, K., Mao, T., Kuhn, E., Jones, S., Velculescu, V. E., Kurman, R. J., & Wang, T. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.009 · Cited by 100
Self-citationSehdev, A. E. S., Kurman, R. J., Kuhn, E., & Shih, I. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.60 · Cited by 95
Self-citationDiagnostic Reproducibility of Hydatidiform Moles
VANG, R. S., Gupta, M., Wu, L.-S.-F., Yemelyanova, A. V., Kurman, R. J., Murphy, K. M., DeScipio, C., & Ronnett, B. M. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31823b13fe · Cited by 93
Karst, A. M., Levanon, K., Duraisamy, S., Liu, J. F., Hirsch, M. S., Hecht, J. L., & Drapkin, R. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.05.021 · Cited by 92
Powell, C. B., Swisher, E. M., Cass, I. A., McLennan, J., Norquist, B. M., Garcia, R. L., Lester, J., Karlan, B. Y., & Chen, L. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.01.029 · Cited by 92
Incessant ovulation and ovarian cancer - a hypothesis re-visited.
Fathalla, M. F. (2013) · PubMed Central · Cited by 91
Huang, H.-S., Chu, S., Hsu, C., Chen, P., Ding, D., Chang, M.-Y., & Chu, T. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv132 · Cited by 89
Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study
Visvanathan, K., Shaw, P. H., May, B. J., Bahadirli-Talbott, A., Kaushiva, A., Risch, H. A., Narod, S. A., Wang, T., Parkash, V., VANG, R. S., et al. (2018) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-18-0009 · Cited by 85
Self-citationMorrison, J. C., Blanco, L. Z., Vang, R., & Ronnett, B. M. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000352 · Cited by 84
Wu, N., Huang, H.-S., Chao, T. H., Chou, H. M., Fang, C., Qin, C.-Z., Lin, C.-Y., Chu, T., & Zhou, H. H. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.049 · Cited by 79
Kobayashi, Y., Kashima, H., Wu, R., Jung, J.-G., Kuan, J.-C., Gu, J., Xuan, J., Sokoll, L. J., Visvanathan, K., Shih, I., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3368 · Cited by 65
Self-citationPisanic, T. R., Cope, L., Lin, S., Yen, T., Athamanolap, P., Asaka, R., Nakayama, K., Fader, A. N., Wang, T., Shih, I., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1199 · Cited by 62
Self-citationStathmin 1 and p16INK4A are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma
Novak, M., Lester, J., Karst, A. M., Parkash, V., Hirsch, M. S., Crum, C. P., Karlan, B. Y., & Drapkin, R. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.07.100 · Cited by 60
Shih, I., Chen, L., Wang, C., Gu, J., Davidson, B., Cope, L., Kurman, R. J., Xuan, J., & Wang, T. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.08.003 · Cited by 58
Self-citationKuhn, E., Kurman, R. J., Soslow, R. A., Han, G., Sehdev, A. E. S., Morin, P., Wang, T., & Shih, I. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31825ec07a · Cited by 57
Self-citationTelomere length variation in biliary tract metaplasia, dysplasia, and carcinoma
Hansel, D. E., Meeker, A. K., Hicks, J. L., Marzo, A. M. D., Lillemoe, K. D., Schulick, R. D., Hruban, R. H., Maitra, A., & Argani, P. (2006) · Modern Pathology · doi:10.1038/modpathol.3800591 · Cited by 57
Genome‐wide mutation analysis in precancerous lesions of endometrial carcinoma
Li, L., Yue, P., Song, Q., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5566 · Cited by 57
Pisanic, T. R., Asaka, S., Lin, S., Yen, T., Sun, H., Bahadirli-Talbott, A., Wang, T., Burns, K. H., Wang, T., & Shih, I. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.11.005 · Cited by 56
Self-citationIGF-axis confers transformation and regeneration of fallopian tube fimbria epithelium upon ovulation
Hsu, C., Huang, H.-S., Chen, P., Ding, D., & Chu, T. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.01.061 · Cited by 51
Wu, N., Fang, C., Huang, H.-S., Wang, J., & Chu, T. (2019) · Modern Pathology · doi:10.1038/s41379-019-0370-1 · Cited by 51
Chui, M. H., Xing, D., Zeppernick, F. A., Wang, Z. Q., Hannibal, C. G., Frederiksen, K., Kjær, S. K., Cope, L., Kurman, R. J., Shih, I., et al. (2019) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001325 · Cited by 47
Self-citationSoong, T. R., Kolin, D. L., Teschan, N., & Crum, C. P. (2018) · Cancers · doi:10.3390/cancers10120468 · Cited by 46
Garg, K., Park, K. J., & Soslow, R. A. (2012) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31824ae6f2 · Cited by 42
Alwosaibai, K., Abedini, A., Al-Hujaily, E. M., Tang, Y., Garson, K., Collins, O. M., & Vanderhyden, B. C. (2017) · Oncotarget · doi:10.18632/oncotarget.20173 · Cited by 40
Chen, L., Huang, R., Chan, M. W., Yan, P. S., Huang, T., Wu, R., Rahmanto, Y. S., Su, P., Weng, Y., Chou, J., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5266 · Cited by 38
Self-citationKawai, T., Hiroi, S., Nakanishi, K., & Meeker, A. K. (2007) · American Journal of Clinical Pathology · doi:10.1309/91py0rbd9w8y5gnx · Cited by 37
Methylomic Landscapes of Ovarian Cancer Precursor Lesions
Pisanic, T. R., Wang, Y., Sun, H., Considine, M., Li, L., Wang, T., Wang, T., & Shih, I. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-0270 · Cited by 36
Self-citationMurali, R., Selenica, P., Brown, D. N., Cheetham, R. K., Chandramohan, R., Claros, N., Bouvier, N., Cheng, D. T., Soslow, R. A., Weigelt, B., et al. (2018) · Histopathology · doi:10.1111/his.13796 · Cited by 26
Singh, R., & Cho, K. R. (2017) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2017-0231-ra · Cited by 25
Defining the molecular evolution of extrauterine high grade serous carcinoma
Beirne, J., McArt, D. G., Roddy, A. C., McDermott, C., Ferris, J. S., Buckley, N. E., Coulter, P., McCabe, N., Eddie, S. L., Dunne, P. D., et al. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.08.029 · Cited by 22
Finch, A., Metcalfe, K. A., Lui, J., Springate, C., Demsky, R., Armel, S. R., Rosen, B. P., Murphy, J., Elit, L., Sun, P., et al. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01117.x · Cited by 21
Fallopian tube abnormalities in uterine serous carcinoma
Steenbeek, M. P., Bulten, J., Snijders, M. P. L. M., Lombaers, M. S., HENDRIKS, J. G. M., van den Brand, M., Kraayenbrink, A. A., Massuger, L. F. A. G., Sweegers, S., de Hullu, J. A., et al. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.04.707 · Cited by 16
Asaka, S., Davis, C., Lin, S., Wang, T., Heaphy, C. M., & Shih, I. (2019) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001283 · Cited by 15
Self-citationDNA Methylation as a Robust Classifier of Epithelial Ovarian Cancer
Ishak, C. A., Lheureux, S., & Carvalho, D. D. D. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1797 · Cited by 11
Cited by
Global epidemiology of epithelial ovarian cancer
Webb, P. M., & Jordan, S. J. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00881-3 · Cited by 571
Metadata
- Authors
- Shih, I.-M., Wang, Y., & Wang, T.-L.
- Venue
- The American Journal of Pathology
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 191
- Issue
- 1
- Pages
- 26-39
- ISSN
- 0002-9440 (ISSN-L)
- OpenAlex
- W3091480325
- Cited by
- 255
- References
- 83
- FWCI
- 18.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.